Related Experiment Video
Updated: Jul 14, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Complication risk with pulse generator change: implications when reacting to a device advisory or recall
Suraj Kapa1, Linda Hyberger, Robert F Rea
1Division of Cardiology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Generator replacement in patients with pacemakers and implantable cardioverter-defibrillators (ICDs) has a low complication rate of 1.24%. Decisions for generator changes should consider these risks, especially for advisory devices.
Area of Science:
- Cardiology
- Medical Device Management
Background:
- Recent pacemakers and implantable cardioverter-defibrillators (ICDs) advisories and recalls necessitate evidence-based management recommendations.
- Evaluating risks and benefits of generator changes in patients with advisory devices is crucial.
Purpose of the Study:
- To assess operative complication rates associated with pulse generator changes in patients with pacemakers and ICDs.
Main Methods:
- A retrospective review of 732 pulse generator changes at Mayo Clinic-Rochester (2000-2005).
- Analysis included 570 elective replacement indicator (ERI) changes and 162 for manufacturer advisories/recalls.
- Complications defined as reoperations within 60 days for infection, hematoma, or incisional dehiscence.
Main Results:
- Overall complication rate was 1.24% (9 of 732 patients).
- Complications occurred in 1.40% of ERI changes (8 patients) and 0.62% of advisory/recall changes (1 patient).
- Specific complications included 5 infections, 3 hematomas, and 1 incisional dehiscence.
Conclusions:
- Pulse generator replacement is a procedure with inherent risks.
- Management decisions for patients with advisory or recalled devices must carefully weigh these operative risks against other clinical factors.
More Related Videos
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Special considerations while measuring pulse
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Assessment of apical radial pulse
The A-R pulse assessment involves simultaneous evaluation of the apical and radial pulses. When the apical and radial pulse rates vary, this assessment helps identify a pulse deficit.
Pre-Procedural Preparation
FDA Approved Drugs: Changes to Approved Drugs
Errors occurring during blood pressure monitoring
Several factors...
